1.           Introduction

1.1       Report Guidance

1.2       Market Segmentation

2.           Executive Summary

2.1       Key Insights

3.           Research Methodology

3.1       Secondary Research

3.2       Primary Research

3.2.1           Hypothesis formulation:

3.2.2           Macroeconomic factor analysis:

3.2.3           Developing base number:

3.2.4           Data Triangulation:

3.2.5           Country-level data:

4.           North America Human Microbiome Market Landscape

4.1       Overview

4.2       PEST Analysis

5.           North America Human Microbiome Market – Key Market Dynamics

5.1       Market Drivers

5.1.1           Significant Investments by Key Market Players

5.1.2           Government Initiatives

5.2       Market Restraints

5.2.1           Challenges During Production of Microbiome

5.3       Market Opportunities

5.3.1           Robust Investment in Research and Development

5.4       Future Trends

5.4.1           Emergence of Precision Medicine

5.5       Impact of Drivers and Restraints:

6.           North America Human Microbiome Market – Analysis

6.1       North America Human Microbiome Market Revenue (US$ Million), 2021–2031

6.2       North America Human Microbiome Market Forecast Analysis

7.           North America Human Microbiome Market Analysis – by Type

7.1       Product

7.1.1           Overview

7.1.2           Product: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

7.2       Software and Services

7.2.1           Overview

7.2.2           Software and Services: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.           North America Human Microbiome Market Analysis – by Application

8.1       Therapeutics

8.1.1           Overview

8.1.2           Therapeutics: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.2       Diagnostics

8.2.1           Overview

8.2.2           Diagnostics: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

8.3       Research

8.3.1           Overview

8.3.2           Research: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.           North America Human Microbiome Market Analysis – by Disease Type

9.1       Obesity

9.1.1           Overview

9.1.2           Obesity: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.2       Diabetes

9.2.1           Overview

9.2.2           Diabetes: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.3       Autoimmune Disorder

9.3.1           Overview

9.3.2           Autoimmune Disorder: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.4       Cancer

9.4.1           Overview

9.4.2           Cancer: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.5       GIT

9.5.1           Overview

9.5.2           GIT: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

9.6       Others

9.6.1           Overview

9.6.2           Others: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.        North America Human Microbiome Market – Country Analysis

10.1     North America

10.1.1         North America Human Microbiome Market – Revenue and Forecast Analysis – by Country

10.1.1.1     North America Human Microbiome Market – Revenue and Forecast Analysis – by Country

10.1.1.2     United States: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.1.1.2.1     United States: North America Human Microbiome Market Share – by Type

10.1.1.2.2     United States: North America Human Microbiome Market Share – by Product

10.1.1.2.3     United States: North America Human Microbiome Market Share – by Application

10.1.1.2.4     United States: North America Human Microbiome Market Share – by Disease Type

10.1.1.3     Canada: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.1.1.3.1     Canada: North America Human Microbiome Market Share – by Type

10.1.1.3.2     Canada: North America Human Microbiome Market Share – by Product

10.1.1.3.3     Canada: North America Human Microbiome Market Share – by Application

10.1.1.3.4     Canada: North America Human Microbiome Market Share – by Disease Type

10.1.1.4     Mexico: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

10.1.1.4.1     Mexico: North America Human Microbiome Market Share – by Type

10.1.1.4.2     Mexico: North America Human Microbiome Market Share – by Product

10.1.1.4.3     Mexico: North America Human Microbiome Market Share – by Application

10.1.1.4.4     Mexico: North America Human Microbiome Market Share – by Disease Type

11.        Competitive Landscape

11.1     Heat Map Analysis by Key Players

11.2     Company Positioning and Concentration

12.        Industry Landscape

12.1     Overview

12.2     Growth Strategies in the Human Microbiome Market

12.3     Organic Growth Strategies

12.3.1         Overview

12.4     Inorganic Growth Strategies

12.4.1         Overview

13.        Company Profiles

13.1.1         Key Facts

13.1.2         Business Description

13.1.3         Products and Services

13.1.4         Financial Overview

13.1.5         SWOT Analysis

13.1.6         Key Developments

13.2     Ferring Holdings SA

13.2.1         Key Facts

13.2.2         Business Description

13.2.3         Products and Services

13.2.4         Financial Overview

13.2.5         SWOT Analysis

13.2.6         Key Developments

13.3     AOBiome Therapeutics Inc

13.3.1         Key Facts

13.3.2         Business Description

13.3.3         Products and Services

13.3.4         Financial Overview

13.3.5         SWOT Analysis

13.3.6         Key Developments

13.4     Finch Therapeutics Group Inc

13.4.1         Key Facts

13.4.2         Business Description

13.4.3         Financial Overview

13.4.4         SWOT Analysis

13.4.5         Key Developments

13.5     Seres Therapeutics Inc

13.5.1         Key Facts

13.5.2         Business Description

13.5.3         Products and Services

13.5.4         Financial Overview

13.5.5         SWOT Analysis

13.5.6         Key Developments

13.6     Merck & Co Inc

13.6.1         Key Facts

13.6.2         Business Description

13.6.3         Products and Services

13.6.4         Financial Overview

13.6.5         SWOT Analysis

13.6.6         Key Developments

13.7     Yakult Honsha Co., Ltd.

13.7.1         Key Facts

13.7.2         Business Description

13.7.3         Products and Services

13.7.4         Financial Overview

13.7.5         SWOT Analysis

13.7.6         Key Developments

13.8     Rebiotix, Inc.

13.8.1         Key Facts

13.8.2         Business Description

13.8.3         Products and Services

13.8.4         Financial Overview

13.8.5         SWOT Analysis

13.8.6         Key Developments

13.9     IFF Nutrition & Biosciences

13.9.1         Key Facts

13.9.2         Business Description

13.9.3         Products and Services

13.9.4         Financial Overview

13.9.5         SWOT Analysis

13.9.6         Key Developments

13.10  Synthetic Biologics, Inc.

13.10.1      Key Facts

13.10.2      Business Description

13.10.3      Products and Services

13.10.4      Financial Overview

13.10.5      SWOT Analysis

13.10.6      Key Developments

14.        Appendix

14.1     About Us

14.2     List of Abbreviations

List of Tables

Table 1.             North America Human Microbiome Market Segmentation

Table 2.             North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Table 3.             North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Type

Table 4.             North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Application

Table 5.             North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Disease Type

Table 6.             North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million) – by Country

Table 7.             United States: North America Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 8.             United States: North America Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Product

Table 9.             United States: North America Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 10.          United States: North America Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease Type

Table 11.          Canada: North America Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 12.          Canada: North America Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Product

Table 13.          Canada: North America Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 14.          Canada: North America Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease Type

Table 15.          Mexico: North America Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Type

Table 16.          Mexico: North America Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Product

Table 17.          Mexico: North America Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Application

Table 18.          Mexico: North America Human Microbiome Market – Revenue and Forecast, 2021 – 2031 (US$ Million) – by Disease Type

Table 19.          Recent Organic Growth Strategies in the Human Microbiome Market

Table 20.          Recent Inorganic Growth Strategies in the Human Microbiome Market

Table 21.          List of Abbreviations

List of Figures

Figure 1.           North America Human Microbiome Market Segmentation – Country

Figure 2.           PEST Analysis

Figure 3.           North America Human Microbiome Market – Key Market Dynamics

Figure 4.           Impact Analysis of Drivers and Restraints

Figure 5.           North America Human Microbiome Market Revenue (US$ Million), 2021–2031

Figure 6.           North America Human Microbiome Market Share (%) – by Type (2023 and 2031)

Figure 7.           Product: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 8.           Software and Services: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 9.           North America Human Microbiome Market Share (%) – by Application (2023 and 2031)

Figure 10.        Therapeutics: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 11.        Diagnostics: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 12.        Research: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 13.        North America Human Microbiome Market Share (%) – by Disease Type (2023 and 2031)

Figure 14.        Obesity: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 15.        Diabetes: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 16.        Autoimmune Disorder: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 17.        Cancer: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 18.        GIT: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 19.        Others: North America Human Microbiome Market – Revenue and Forecast, 2021–2031 (US$ Million)

Figure 20.        North America Human Microbiome Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 21.        United States: North America Human Microbiome Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 22.        Canada: North America Human Microbiome Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 23.        Mexico: North America Human Microbiome Market – Revenue and Forecast, 2021– 2031 (US$ Million)

Figure 24.        Heat Map Analysis by Key Players

Figure 25.        Company Positioning and Concentration

Figure 26.        Growth Strategies in the Human Microbiome Market